AI Terminal
Serco Group PLC
Director's Dealing • Dec 24, 2021
5273_dirs_2021-12-24_766d9c64-85b3-4e99-b84b-597aee37ec19.html
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 7968W
Serco Group PLC
24 December 2021
24 December 2021
Serco Group plc
Legal Entity Identifier: 549300PT2CIHYN5GWJ21
INITIAL NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMRs') IN ORDINARY SHARES OF 2p EACH IN THE COMPANY ('Ordinary Shares')
On 23 December 2021, Kate Steadman, Group Strategy and Communications Director, exercised nominal-cost options granted under the 2009 Serco Performance Share Plan and, on the same date, sold Ordinary Shares to satisfy tax liabilities and dealing costs as set out below.
A summary of the Ordinary Shares acquired, sold and retained is set out below.
| Grant date of award | Vest date of award | Number of Ordinary Shares acquired | Ordinary Shares sold | Share price (GBP) | Number of Ordinary Shares retained |
| 6 April 2016 | 6 April 2019 | 89,577 | 42,962 | £1.335899 | 46,615 |
| 6 April 2017 | 6 April 2020 | 106,194 | 50,932 | £1.335899 | 55,262 |
| 25 June 2018 | 25 June 2021 | 186,401 | 89,402 | £1.335899 | 96,999 |
This announcement is made in accordance with the requirements of Article 19 of the EU Market Abuse Regulation 596/2014.
The notification of dealing forms for this transaction can be found below.
Transaction notification
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Kate Steadman
2
Reason for the notification
a)
Position/status
Group Strategy and Communications Director
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Serco Group plc
b)
LEI
549300PT2CIHYN5GWJ21
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares of 2 pence each ('Ordinary Shares')
Identification code
ISIN: GB0007973794
b)
Nature of the transaction
The exercise of nominal-cost options over Ordinary Shares granted on 29 6 April 2016, 6 April 2017 and 25 June 2018 under the Company's 2009 Performance Share Plan.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £0.02 | 89,577 |
| £0.02 | 106,194 |
| £0.02 | 186,401 |
d)
Aggregated information
- Aggregated volume
382,172
- Price
£7,643.44
e)
Date of the transaction
23 December 2021
f)
Place of the transaction
N/A
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares of 2 pence each ('Ordinary Shares')
Identification code
ISIN: GB0007973794
b)
Nature of the transaction
The sale of Ordinary Shares following the exercise of nominal-cost options over Ordinary Shares on 23 December 2021 under the Company's 2009 Performance Share Plan.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £1.335899 | 42,962 |
| £1.335899 | 50,932 |
| £1.335899 | 89,402 |
d)
Aggregated information
- Aggregated volume
183,296
- Price
£244,864.94
e)
Date of the transaction
23 December 2021
f)
Place of the transaction
London Stock Exchange (XLON)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHUSSARAKUUUAA